Valuation: Cochlear Limited

Market Cap 9.81B 6.49B 5.92B 5.45B 4.96B 9.3B 601B 66.33B 26.4B 328B 24.34B 23.83B 1,029B P/E 2027 *
33.2x
P/E 2028 * 26.4x
Enterprise Value 9.58B 6.34B 5.78B 5.32B 4.84B 9.08B 587B 64.77B 25.78B 320B 23.77B 23.27B 1,005B EV / Sales 2027 *
4.04x
EV / Sales 2028 * 3.79x
Free-Float
99.42%
Yield 2027 *
2.4%
Yield 2028 * 2.65%
1 day-2.52%
1 week-0.91%
Current month+4.42%
1 month+7.60%
3 months+9.63%
6 months+58.27%
Current year-42.46%
1 week 147.63
Extreme 147.63
154.8
1 month 137.98
Extreme 137.98
155.72
Current year 88.74
Extreme 88.74
278.35
1 year 88.74
Extreme 88.74
284.88
3 years 88.74
Extreme 88.74
350.31
5 years 88.74
Extreme 88.74
350.31
10 years 88.74
Extreme 88.74
350.31
Manager TitleAgeSince
Chief Executive Officer - 2018-01-02
Director of Finance/CFO - 2024-12-31
Chief Tech/Sci/R&D Officer - 2019-06-30
Director TitleAgeSince
Chairman 58 2021-08-20
Director/Board Member - 2017-11-13
Director/Board Member 69 2016-12-12
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Buy

Director

1,100 0.0017%
8/24/26 Buy

Director

444 0.0007%
8/24/26 Buy

Director

257 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-2.52%-0.91%-44.33%-42.59% 6.52B
-0.84%-5.09%-16.92%+1.78% 178B
-0.67%-2.84%+0.59%+32.97% 122B
-0.98%+0.12%-14.00%+7.16% 118B
-1.24%-4.25%-43.89%-1.12% 88.1B
-0.63%-5.55%-6.35%+73.06% 64.71B
+0.05%-2.41%+12.24%-8.94% 57.96B
-1.95%-3.98%-1.91%+42.98% 53.28B
-2.91%-4.35%-0.82%+38.03% 47.8B
-1.64%+1.50%+2.30%-1.14% 35.65B
Average -1.33%-2.45%-11.31%+14.22% 77B
Weighted average by Cap. -1.05%-2.95%-11.02%+16.95%

Financials

2027 *2028 *
Net sales 2.37B 1.57B 1.43B 1.32B 1.2B 2.25B 145B 16.04B 6.38B 79.32B 5.89B 5.76B 249B 2.51B 1.66B 1.51B 1.39B 1.27B 2.38B 154B 16.94B 6.74B 83.79B 6.22B 6.09B 263B
Net income 293M 194M 177M 163M 148M 278M 17.99B 1.98B 790M 9.81B 728M 713M 30.79B 371M 245M 224M 206M 187M 352M 22.74B 2.51B 998M 12.41B 921M 901M 38.92B
Net Debt -230M -152M -139M -128M -116M -218M -14.12B -1.56B -620M -7.7B -572M -560M -24.17B -312M -206M -188M -173M -158M -296M -19.12B -2.11B -839M -10.43B -774M -758M -32.73B
Projected Income Statement - Annual - Cochlear Limited
Logo Cochlear Limited
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services and Acoustics. The Cochlear Implants segment offers Cochlear implant systems. The Services segment offers sound processor upgrades, accessories and other. The Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Employees
5,400
Date Price Change Volume
26-11-20 A$149.99 -2.52% 236,158
26-11-19 A$153.87 +0.46% 239,973
26-11-18 A$153.17 +0.40% 253,175
26-11-17 A$152.56 +1.15% 205,086
26-11-16 A$150.83 -0.36% 149,534
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Cochlear Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
149.99AUD
Average target price
136.34AUD
Spread / Average Target
-9.10%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cochlear Limited